Ureteroscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: May 10, 2024 Report Code: GDME1738EPD-ST

Select Item

Ureteroscopes Pipeline Market Report Overview

Ureteroscope is an endoscope used for examining the upper urinary tract. A ureteroscope is inserted into the bladder and ureter and is used to diagnose and treat a variety of problems in the urinary tract. Physicians can use Ureteroscopes to remove kidney stones.

The ureteroscopes pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Single-Use Flexible Ureteroscopes

·       Flexible Ureteroscopes
Key Territories ·       The US

·       China

·       Japan
Key Regulatory Paths ·       510 (K)

·       Ninsho

·       NMPA
Leading Companies ·       Ambu A/S

·       Becton Dickinson and Co

·       Children’s Research Institute

·       MicroPort Scientific Corp

·       Olympus Corp
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Ureteroscopes Pipeline Market Segmentation by Segments

The key segments for the ureteroscopes pipeline market are single-use flexible ureteroscopes and flexible ureteroscopes. As of May 2024, single-use flexible ureteroscopes account for the highest share of pipeline products.

Single-use flexible ureteroscopes are used to examine the upper urinary tract. They are inserted into the bladder and ureter and used to diagnose and treat a variety of urinary tract conditions.

Ureteroscopes Pipeline Market Analysis by Segments, 2024 (%)

Ureteroscopes Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Ureteroscopes Pipeline Market

Download a Free Report Sample

Ureteroscopes Pipeline Market Segmentation by Territories

A few of the key territories with the ureteroscopes pipeline market are the US, China, and Japan. As of May 2024, the United States (US) accounts for the highest number of pipeline products.

Ureteroscopes Pipeline Market Analysis by Territories, 2024 (%)

Ureteroscopes Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Ureteroscopes Pipeline Market

Download a Free Report Sample

Ureteroscopes Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the ureteroscopes pipeline products market are 510(k), Ninsho, and NMPA. As of May 2024, 510(k) is the most followed pathway for pipeline products in the ureteroscopes market.

Ureteroscopes Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Ureteroscopes Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Ureteroscopes Pipeline Market

Download a Free Report Sample

Ureteroscopes Pipeline Market – Competitive Landscape

A few of the key companies associated with the ureteroscopes pipeline market are Ambu A/S, Becton Dickinson and Co., Children’s Research Institute, MicroPort Scientific Corp, and Olympus Corp, among others.

Ambu A/S: Ambu A/S (Ambu) is a medical device company that manufactures and markets life-supporting devices. It focuses on single-use devices for anesthesia, endoscopy, cardiology, patient monitoring and diagnostics, and emergency care. It serves hospitals, clinics, sleep laboratories, and rescue services.

Becton Dickinson and Co: Becton Dickinson and Co (BD) is a medical technology company, which manufactures and sells medical devices, reagents, and instruments. BD offers its products for life science researchers, healthcare institutions, clinical laboratories, the pharmaceutical industry, and the public. The company markets its products in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. BD is headquartered in New Jersey, the US.

Ureteroscopes Pipeline Market Analysis by Companies, 2024

Ureteroscopes Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Ureteroscopes Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Ureteroscopes Pipeline Market Segments Outlook (2024)

  • Single-Use Flexible Ureteroscopes
  • Flexible Ureteroscopes

Ureteroscopes Pipeline Market Territories Outlook (2024)

  • The US
  • China
  • Japan

Ureteroscopes Pipeline Market Regulatory Paths Outlook (2024)

  • 510 (K)
  • Ninsho
  • NMPA

Scope

This report provides:

  • Extensive coverage of the ureteroscopes under development.

  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of ureteroscopes and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of ureteroscopes under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Ambu A/S
Becton Dickinson and Co
Children's Research Institute
Dyne Medical Group Inc
Hangzhou Kangji Medical Instrument Co Ltd
Innovex Medical Co Ltd
MicroPort Scientific Corp
Olympus Corp
Temple University Health System
University of California
University of California Irvine

Table of Contents

1 Table of Contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Ureteroscopes Overview 7

3 Products under Development 8

3.1 Ureteroscopes – Pipeline Products by Stage of Development 8

3.2 Ureteroscopes – Pipeline Products by Segment 9

3.3 Ureteroscopes – Pipeline Products by Territory 10

3.4 Ureteroscopes – Pipeline Products by Regulatory Path 11

3.5 Ureteroscopes – Pipeline Products by Estimated Approval Date 12

4 Ureteroscopes – Pipeline Products under Development by Companies 13

4.1 Ureteroscopes Companies – Pipeline Products by Stage of Development 13

4.2 Ureteroscopes – Pipeline Products by Stage of Development 14

5 Ureteroscopes Companies and Product Overview 15

5.1 Ambu A/S Company Overview 15

5.1.1 Ambu A/S Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 Becton Dickinson and Co Company Overview 16

5.2.1 Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 16

5.3 Children’s Research Institute Company Overview 17

5.3.1 Children’s Research Institute Pipeline Products & Ongoing Clinical Trials Overview 17

5.4 Dyne Medical Group Inc Company Overview 18

5.4.1 Dyne Medical Group Inc Pipeline Products & Ongoing Clinical Trials Overview 18

5.5 Hangzhou Kangji Medical Instrument Co Ltd Company Overview 19

5.5.1 Hangzhou Kangji Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

5.6 Innovex Medical Co Ltd Company Overview 20

5.6.1 Innovex Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

5.7 MicroPort Scientific Corp Company Overview 21

5.7.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 21

5.8 Olympus Corp Company Overview 22

5.8.1 Olympus Corp Pipeline Products & Ongoing Clinical Trials Overview 22

5.9 Temple University Health System Company Overview 23

5.9.1 Temple University Health System Pipeline Products & Ongoing Clinical Trials Overview 23

5.10 University of California Company Overview 24

5.10.1 University of California Pipeline Products & Ongoing Clinical Trials Overview 24

5.11 University of California Irvine Company Overview 25

5.11.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 25

6 Ureteroscopes- Recent Developments 26

6.1 Apr 30, 2024: Olympus to Highlight Diverse Treatment Portfolio at American Urological Association Annual Meeting 26

6.2 Apr 30, 2024: Cook Medical now offering Ascend Single-Use Flexible Ureteroscope in US and Canada 27

6.3 Apr 10, 2024: Gyrus Receives FDA 510(k) Clearance for RenaFlex Single-use Flexible Ureteroscope 28

6.4 Apr 02, 2024: Olympus Announces FDA Clearance of Renaflex, its First Single-use Flexible Ureteroscope 28

6.5 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company 29

6.6 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering 29

6.7 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent 29

6.8 Jan 31, 2024: Stryker Corp Reports Strong Q4 and Full Year 2023 Results; Forecasts Continued Growth 29

6.9 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 29

6.10 Jan 26, 2024: Shenzhen Macrolux Medical Technology Receives FDA 510(k) Clearance for CoralView Single-use Digital Flexible Ureteroscope 31

6.11 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results 32

6.12 Jan 02, 2024: Boston Scientific Receives 510(K) Clearance For LithoVue Elite Single-Use Digital Flexible Ureteroscope 32

6.13 Nov 15, 2023: HUGER Medical Instruments Receives 510(K) Clearance For Medical Video Endoscope System 32

6.14 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023 32

6.15 Oct 09, 2023: Stryker to Host Investor Day 34

6.16 Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023 34

6.17 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer 34

6.18 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources 35

6.19 Aug 17, 2023: CenterPoint Systems Receives 510(k) Clearance for RenaNav Ureteroscope System 35

6.20 Aug 15, 2023: Steris Receives Additional 510(k) Clearance for Uretero1 Ureteroscope System 35

6.21 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 36

6.22 Jun 07, 2023: Hunan Vathin Medical Instrument receives 510(k) clearance for the Flexible Video Bronchoscope 36

7 Appendix 37

7.1 Methodology 37

7.2 About GlobalData 40

7.3 Contact Us 40

7.4 Disclaimer 40

Table

Ureteroscopes – Pipeline Products by Stage of Development 8

Ureteroscopes – Pipeline Products by Segment 9

Ureteroscopes – Pipeline Products by Territory 10

Ureteroscopes – Pipeline Products by Regulatory Path 11

Ureteroscopes – Pipeline Products by Estimated Approval Date 12

Ureteroscopes Companies – Pipeline Products by Stage of Development 13

Ureteroscopes – Pipeline Products by Stage of Development 14

Ambu A/S Pipeline Products & Ongoing Clinical Trials Overview 15

Ambu aScope Ureteroscope – Product Status 15

Ambu aScope Ureteroscope – Product Description 15

Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 16

Ureteroscope – Product Status 16

Ureteroscope – Product Description 16

Children’s Research Institute Pipeline Products & Ongoing Clinical Trials Overview 17

Software – Robotically-Assisted Ureteroscopy – Product Status 17

Software – Robotically-Assisted Ureteroscopy – Product Description 17

Dyne Medical Group Inc Pipeline Products & Ongoing Clinical Trials Overview 18

URUS – Product Status 18

URUS – Product Description 18

Hangzhou Kangji Medical Instrument Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

Single-use Electronic Ureteroscope – Product Status 19

Single-use Electronic Ureteroscope – Product Description 19

Innovex Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 20

Single-Use Ureterorenoscope (1.0) – Product Status 20

Single-Use Ureterorenoscope (1.0) – Product Description 20

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 21

Single-Use Urological Endoscope – Product Status 21

Single-Use Urological Endoscope – Product Description 21

Olympus Corp Pipeline Products & Ongoing Clinical Trials Overview 22

Single-Use Ureteroscope – Product Status 22

Single-Use Ureteroscope – Product Description 22

Temple University Health System Pipeline Products & Ongoing Clinical Trials Overview 23

Endoscopic Device – Urothelial Carcinoma – Product Status 23

Endoscopic Device – Urothelial Carcinoma – Product Description 23

University of California Pipeline Products & Ongoing Clinical Trials Overview 24

Aspiration Endoscope Device – Product Status 24

Aspiration Endoscope Device – Product Description 24

University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 25

Ureteroscope – Product Status 25

Ureteroscope – Product Description 25

Glossary 39

Figures

Ureteroscopes – Pipeline Products by Stage of Development 8

Ureteroscopes – Pipeline Products by Segment 9

Ureteroscopes – Pipeline Products by Territory 10

Ureteroscopes – Pipeline Products by Regulatory Path 11

Ureteroscopes – Pipeline Products by Estimated Approval Date 12

Frequently asked questions

Ureteroscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Ureteroscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Ureteroscopes reports
Medical Devices
New
Venous Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures…
$7,500 | April 2024
Medical Devices
New
Germany Surgical Stapling Devices Market Size (Value, Volume, ASP) by…
$500 | May 2024
Medical Devices
New
India Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | May 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Ureteroscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Ureteroscopes Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more